Dear Internal Market, Industry, Entrepreneurship and SMEs,

On behalf of Corporate Europe Observatory (CEO), I would like to - under the right of access to documents in the EU treaties as developed in Regulation 1049/2001 - request access to the following documents:

- all reports (and other notes) from meetings between DG GROW and representatives of the pharmaceutical industry (companies as well as organisations such as EFPIA) from December 1st 2019 onwards. This should include the following companies: Bayer AG, Novartis International AG, Merck, GlaxoSmithKline, Amgen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, SANOFI, Pfizer Inc., AstraZeneca, Eli Lilly and Company, and MSD (Europe) Inc. (Merck Sharp & Dohme).

- all correspondence (including emails) between the DG GROW and representatives of the pharmaceutical industry (companies as well as organisations such as EFPIA) from December 1st 2019 onwards.

- a list of all the above-mentioned documents (including dates, names of participants/senders/recipients and their affiliation, subject of meeting/correspondence)

Yours faithfully,
Olivier Hoedeman

on behalf of Corporate Europe Observatory (CEO)
Corporate Europe Observatory (CEO)
Rue d'Edimbourg 26,
1050 Brussels, Belgium

http://www.corporateeurope.org
Tel. +32 (0)2 893 0930
Mobile: +32 474 486545
EU Transparency Register ID Number: 5353162366-85

Internal Market, Industry, Entrepreneurship and SMEs

1 Attachment

Dear Mr Hoedeman,

 

Thank you for your e-mail dated 14/01/2020.  We hereby acknowledge receipt
of your application for access to documents, which was registered on
16/01/2020 under reference number GestDem 2020/0311.

 

In accordance with Regulation (EC) No 1049/2001 regarding public access to
European Parliament, Council and Commission documents, your application
will be handled within 15 working days. The time limit will expire on
06/02/2020. In case this time limit needs to be extended, you will be
informed in due course.

 

You have lodged your application via the AsktheEU.org website. Please note
that this is a private website which has no link with any institution of
the European Union. Therefore the European Commission cannot be held
accountable for any technical issues or problems linked to the use of this
system.

 

Please note also that the European Commission is not responsible for any
possible processing of personal data by the private organisation running
the AsktheEU.org website, through which you have channelled your request.
Please refer to their privacy policy.

 

Yours sincerely, 

 

DG GROW – Access to documents team

 

[1]cid:479385507@17082012-2045

European Commission
Directorate-General for Internal Market, Industry, Entrepreneurship and
SMEs
DG  GROW/01 – Coordination and Planning

 

 

References

Visible links

Internal Market, Industry, Entrepreneurship and SMEs

1 Attachment

Dear Mr Hoedeman,

 

We refer to your e-mail dated 14/01/2020 in which you make a request for
access to documents, registered on 16/01/2020 under the above mentioned
reference number.

Your application is currently being handled. However, we will not be in a
position to complete the handling of your application within the time
limit of 15 working days, which expires today.

 

Therefore, we have to extend the time limit with 15 working days in
accordance with Article 7(3) of Regulation (EC) No 1049/2001 regarding
public access to documents. The new time limit expires on 27/02/2020.

 

We apologize for this delay and for any inconvenience this may cause.

 

Yours sincerely,

 

DG GROW – Access to documents team

European Commission
Directorate-General for Internal Market, Industry, Entrepreneurship and
SMEs
DG GROW/01 – Coordination and Planning

 

 

JANSEN Klaus, Internal Market, Industry, Entrepreneurship and SMEs

4 Attachments

Link: [1]File-List
Link: [2]Edit-Time-Data
Link: [3]themeData
Link: [4]colorSchemeMapping

[5]Ares(2020)1222839 - Your request for access to documents – GESTDEM
2020/0311

Sent by JANSEN Klaus (GROW) <[email address]>. All responses
have to be sent to this email address.
Envoyé par JANSEN Klaus (GROW) <[email address]>. Toutes les
réponses doivent être effectuées à cette adresse électronique.

Dear Mr Hoedeman,

I refer to your request of 14/01/2020, registered on 16/01/2020 under the
above mentioned GESTDEM reference number.

Your request concerns the following:  “all reports (and other notes) from
meetings between DG SANTE and representatives of the pharmaceutical
industry (companies as well as organisations such as EFPIA) from December
1st 2019 onwards. This should include the following companies: Bayer AG,
Novartis International AG, Merck, GlaxoSmithKline, Amgen Inc, F.
Hoffmann-La Roche Ltd, Johnson & Johnson, SANOFI, Pfizer Inc.,
AstraZeneca, Eli Lilly and Company, and MSD (Europe) Inc. (Merck Sharp &
Dohme). - all correspondence (including emails) between the DG SANTE and
representatives of the pharmaceutical industry (companies as well as
organisations such as EFPIA) from December 1st 2019 onwards. - a list of
all the above-mentioned documents (including dates, names of
participants/senders/recipients and their affiliation, subject of
meeting/correspondence)”

We are pleased to inform you that we will send the documents concerning to
this request attached to this mail. Some parts of those documents have
been blanked out as their disclosure is prevented by exception concerning
protection of privacy and the integrity of an individual as laid down in
Article 4(1)(b) of the Regulation No 1049/2001.         

Pursuant to Article 4(1)(b) of Regulation (EC) No 1049/2001, access to a
document has to be refused if its disclosure would undermine the
protection of privacy and the integrity of the individual, in particular
in accordance with European Union legislation regarding the protection of
personal data.

Article 9(1)(b) of the Data Protection Regulation does not allow the
transmission of these personal data, except if you prove that it is
necessary to have the data transmitted to you for a specific purpose in
the public interest  and  where there is no reason to assume that the
legitimate interests of the data subject might be prejudiced. In your
request, you do not express any particular interest to have access to
these personal data nor do you put forward any arguments to establish the
necessity to have the data transmitted for a specific purpose in the
public interest.

Consequently, I conclude that, pursuant to Article 4(1)(b) of Regulation
(EC) No 1049/2001, access cannot be granted to the personal data, as the
need to obtain access thereto for a purpose in the public interest has not
been substantiated and there is no reason to think that the legitimate
interests of the individuals concerned would not be prejudiced by
disclosure of the personal data concerned.           

In accordance with Article 7(2) of Regulation (EC) No 1049/2001, you are
entitled to make a confirmatory application requesting the Commission to
review this position.

Such a confirmatory application should be addressed within 15 working days
upon receipt of this letter to the Secretariat-General of the Commission
at the following address:

European Commission

Secretariat-General

Unit C.1. ‘Transparency, Document Management and Access to Documents’

BERL 7/076        
B-1049 Bruxelles, or by email to: [6][email address]

Yours sincerely,

Harrie TEMMINK
Deputy Head of Unit

 

 

 

 

 

Klaus JANSEN
Assistant
 
European Commission
DG for Internal Market, Industry, Entrepreneurship and SMEs
Unit F3 – "Intellectual Property and Fight Against Counterfeiting "

Avenue des Nerviens 105 (N105 09/102)
B-1040 Brussels/Belgium
+32 (0)22 99 66 56
[7][email address]

Follow us on

Facebook:                 [8]EU Growth

Twitter:                      [9]@EU_Growth

Our Websites:         [10]ec.europa.eu/growth

                                      [11]ec.europa.eu/bienkowska

[12]https://myintracomm.ec.europa.eu/dg/grow...

 

 

 

 

 

References

Visible links
1. file:///tmp/cid:filelist.xml@01D5ED4E.3ED2C4D0
2. file:///tmp/cid:editdata.mso
3. file:///tmp/~~themedata~~
4. file:///tmp/~~colorschememapping~~
5. https://webgate.ec.testa.eu/Ares/documen...
6. mailto:[email address]
7. mailto:[email address]
8. http://www.facebook.com/EU.growth
9. http://twitter.com/EU_growth
10. http://ec.europa.eu/growth/index_en.htm
11. http://ec.europa.eu/bienkowska